ProShares Ultra Nasdaq Biotechnology
BIB
#2839
ETF rank
NZ$0.18 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
NZ$210.17
Share price
-1.25%
Change (1 day)
59.48%
Change (1 year)

Expense ratio and fees for ProShares Ultra Nasdaq Biotechnology (BIB)

Expense Ratio

Expense Ratio as of November 2026: 0.95%

Gross Expense Ratio

Gross Expense Ratio as of November 2026: 1.17%

Net Expense Ratio

Net Expense Ratio as of November 2026: 0.95%